All news

Hims & Hers hit with securities class action

Alpha Vantage · GlobeNewswire · · AI-summarised by FinFlash

Bronstein, Gewirtz & Grossman LLC has filed a class action against Hims & Hers Health (NYSE: HIMS) and certain officers, alleging violations of federal securities laws. The suit claims the company made false and misleading statements, including sharing consumer health information with third-party advertisers and charging for prescriptions before medical consultations. Investors who bought Hims securities between August 4, 2025 and July 29, 2026 may seek lead plaintiff status by November 1, 2026.

Read original source

HIMS company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.